| Ticker: | AVBP |
| Current Price: | $16.20 |
| % Daily Change: | 0.68% |
| Volume (1,000s): | 1,589.12 |
| Average Volume (1,000s): | 0.00 |
| Market Cap (M): | $754.51 |
| 1/2/2024 Price: | $20.79 |
| Change Since Inception: | -22.08% |
ArriVent BioPharma, Inc.
18 Campus Boulevard
Suite 100
Newtown Square, PA 19073
United States
ArriVent Biopharma is dedicated to accelerating the global development of innovative biopharmaceutical products. With a deep and global network, ArriVent seeks to access unique and best-in-class drug candidates at various development stages, including those coming from China and other emerging biotech hubs. Through strategic collaborations with innovative biopharma companies, ArriVent aims to globalize medicines for patients with unmet medical need in a broad range of diseases, with an initial focus in oncology.